Bodo Möller Chemie Group has announced the launch of its new Life Sciences business in the IMEA region, covering the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, Bahrain, Lebanon, Jordan, Iraq, and Egypt. This strategic expansion introduces a significant new business line to the company, complementing its established Formulated Systems and Industrial Raw Materials divisions.
The Life Sciences business offers an extensive portfolio of raw materials and ingredients for sectors including human nutrition, pharmaceuticals, personal care, home care, and industrial and institutional care. Bodo Möller Chemie aims to support its clients with innovative solutions and technical expertise, enhanced by laboratory services that prioritize customer and supplier partnerships and operational efficiency.
“With the launch of our Life Sciences business in the IMEA region, we are ready to meet the growing demand for high-quality raw materials and chemicals,” said Frank Haug, CEO of Bodo Möller Chemie Group. “This initiative represents a new strategic dimension for our company, allowing us to diversify and strengthen our position in the Middle East market.”
The Middle East is experiencing an increasing push for local production and self-sufficiency, particularly in pharmaceuticals, food, and care products. “Bodo Möller Chemie’s deep market understanding and industry expertise position us as a key player in this transformation,” said Abdallah Dabaghi, executive vice president, IMEA. With comprehensive market coverage supported by local offices and warehouses, the company provides tailored solutions and technical support through its skilled sales and technical teams.
“As a complexity reducer and solutions provider, we are committed to offering a diversified product portfolio, technical support, and top-tier logistics services,” added Haug. “Our entry into the life sciences market in the IMEA region marks a major milestone aligned with our long-term vision and strategic objectives.”
For more information, visit www.bm-chemie.com.